Popular Pre-Market Trades in U.S. Stocks
Kodiak Sciences is up 4.00% in pre-market trading. According to recent key news:
<ol>
<li>
On September 22, Jefferies initiated coverage on Kodiak Sciences with a buy rating and set a target price of $15. This news drove the stock price up.
</li>
<li>
On September 23, the dual antibody KSI-501 developed by Kodiak Sciences entered Phase III trials, and the market is optimistic about the prospects of its innovative drug, further boosting the stock price.
</li>
<li>
On September 22, although analysts at MarketBeat believe there are better investment options, Kodiak Sciences still received a hold rating from analysts, indicating cautious optimism in the market regarding its future development. The biotechnology industry is active in the research and development of innovative drugs.
</li>
</ol>
Top Gainers in U.S. Pre-Market Trading
Strata Skin Sciences is up 126.47% in pre-market trading. According to recent key news:
<ol>
<li>On September 22, the International Journal of Dermatology published a randomized controlled combination trial initiated by researchers, confirming its superiority over monotherapy. This result has driven sustained market growth and expanded the range of indications, leading to a significant increase in Strata Skin Sciences' stock price. There is an increasing demand for new therapies</li>
</ol>

Kodiak Sciences rose 4.00% in pre-market; Super League Enterprise rose 218.90% in pre-market; Strata Skin Sciences rose 126.47% in pre-market; Professional Divest Network rose 86.36% in pre-market

Pre-market hot trades in US stocks: Kodiak Sciences up 4.00% in pre-market